id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-N-0139-0001,FDA,FDA-1999-N-0139,Progestational Drug Products for Human Use; Requirements for Labeling Directed to the Patient,Notice,NPR-Notice of Proposed Rule-Making,1999-04-19T04:00:00Z,1999,4,1999-04-13T04:00:00Z,1999-07-13T03:59:59Z,2024-11-19T13:53:12Z,99-9146,0,0,09000064804aedfe